Breaking News
February 25, 2018 - New staining method helps analyze 3D tissue samples using Nano-CT system
February 25, 2018 - Rare immune cell may prove to be potent weapon in fighting against cancer
February 25, 2018 - Connection between heart disease and cancer treatment
February 25, 2018 - Longer Endocrine Tx Better in Prostate Cancer
February 25, 2018 - Gene therapy restores normal blood glucose levels in mice with type 1 diabetes
February 25, 2018 - Desymmetrization paves way for new bioactive compounds
February 25, 2018 - Study finds underutilization of less expensive, post-acute care options for older adults
February 25, 2018 - UNIST researchers introduce new biosensing contact lens for diabetics
February 25, 2018 - Research consortium develops first 3D computer model of metabolic processes
February 25, 2018 - Adding hope to health messages may help promote preventative actions, researchers say
February 25, 2018 - Sudden Hearing Loss Recovery Hampered by Metabolic Syndrome
February 25, 2018 - First human trial of potentially game-changing diabetes treatment set to commence
February 25, 2018 - Child’s snacking patterns could be linked to genetics, study finds
February 25, 2018 - Patients with terminal cancer may be less competent to make big decisions
February 25, 2018 - Study highlights risks involved in short-term use of PICCs
February 25, 2018 - Study shows no increase in complications with ‘ad lib’ oral intake during labor
February 25, 2018 - Although Plaquenil (Hydroxychloroquine) Eases Rheumatoid Arthritis Pain it Won’t Help ‘Regular’ Arthritis
February 25, 2018 - Methotrexate May Help in Chronic Viral Arthritis
February 25, 2018 - Lack of guidance may delay a child’s first trip to the dentist
February 25, 2018 - Study shows cost-effectiveness of screening for fracture risk in older postmenopausal women
February 24, 2018 - Younger women with SCAD may benefit most from conservative treatment
February 24, 2018 - Blood Test for Concussion OK’d
February 24, 2018 - What are symptoms of an alcohol use disorder? – Rethinking Drinking
February 24, 2018 - Streamlined, cost-cutting post-treatment dental advice via iPad
February 24, 2018 - Researchers discover new regulator of the immune system
February 24, 2018 - Reducing red tape for traveling nurses
February 24, 2018 - Study supports benefits of meditation in control of attention and emotions
February 24, 2018 - Flu Vax Data ‘Only Tell Half the Story’
February 24, 2018 - Calculators – Rethinking Drinking – NIAAA
February 24, 2018 - From stem cells to a functional heart—the role of the Mesp1 gene
February 24, 2018 - Non-adherence to sleep apnea treatment linked to increased hospital readmissions
February 24, 2018 - Exercise-related posts influence health of social media pals
February 24, 2018 - Will Device Meetings in Europe Suffer Under New Ethics Rule?
February 24, 2018 - Nonstatin drug use increases by 124% in U.S., related expenditures triple
February 24, 2018 - Annual foot screening could help spot heart irregularities in people with diabetes
February 24, 2018 - Researchers developing rapid saliva test to detect Zika virus
February 24, 2018 - For Older Men, Even Light Exercise Helps
February 24, 2018 - Healthy Strategies to Beat Stress
February 24, 2018 - Cancer killing clue could lead to safer and more powerful immunotherapies
February 24, 2018 - Repeated sick days do not affect children’s learning ability, study shows
February 24, 2018 - New two-child policy in China could negatively affect women’s status and gender equality
February 24, 2018 - New research project to determine why mine dust-related lung diseases are on the rise
February 24, 2018 - A Tribute to Dr. Ray Lipicky: The Man Who Transformed Cardiology
February 24, 2018 - ClinicalTrials.gov: Child, Foster
February 24, 2018 - Study shows age doesn’t affect survival in patients with non-Hodgkin lymphoma after HCT
February 24, 2018 - Researchers explore how evolutionary processes guide pathways of cells
February 24, 2018 - Discovery may result in new medication to build stronger muscles in old age
February 24, 2018 - New study identifies possible target for treatment of dangerous allergic reactions
February 24, 2018 - Targeted vaccination can be successful in containing epidemic outbreaks
February 24, 2018 - Loxo Oncology Announces Publication of Larotrectinib Clinical Data in The New England Journal of Medicine
February 24, 2018 - ‘The Best Deals of Any Payer’: What We Heard This Week
February 24, 2018 - Blood and urine tests developed to indicate autism in children
February 24, 2018 - New low-cost microfluidic device brings single-cell technology to bedside
February 24, 2018 - Covestro and Pittsburgh Penguins announce multi-year unique partnership
February 24, 2018 - Children from low-income areas have poor outcomes after heart surgery, study finds
February 24, 2018 - Some genes can drive both metastasis and initial stages of tumor growth
February 24, 2018 - Visaris Americas announces installation of fully robotic Vision C digital X-ray suite at OGHS
February 24, 2018 - New discovery could accelerate clinical translation of stem cell-based therapies
February 24, 2018 - Respiratory disease patients with arthritis struggle to use complex inhalers
February 24, 2018 - FDA Alert: Labetalol Hydrochloride Injection by Hospira: Recall
February 24, 2018 - Flu, Tdap Vax Safe for Babies 6 Months Later
February 24, 2018 - Adults with autism show a diminished brain response to hearing their own name
February 24, 2018 - Study provides insight into neurobiology of dying
February 24, 2018 - Study finds tobacco smoke exposure among most adolescents in economically disadvantaged population
February 24, 2018 - U.S. clinical sites evaluating antibody-based therapies to prevent two common bacterial infections
February 24, 2018 - UCLA researchers use fluorescent colored proteins to trace origin of heart cells
February 24, 2018 - UC Riverside researchers discover way to halt cancer metastasis
February 24, 2018 - Home Routines Can Boost a Child’s Readiness for School
February 24, 2018 - FDA Investigating Misuse, Abuse of Gabapentinoids
February 24, 2018 - Scientists find key proteins control risk of osteoarthritis during aging
February 24, 2018 - Izon announce the launch of the qEV2 and qEV10 Exosome Isolation columns
February 24, 2018 - New CSIRO technology can create clean drinking water
February 24, 2018 - Treating sleep-disordered breathing may improve prognosis of heart failure patients
February 24, 2018 - More boys begin school a year late than girls, study finds
February 24, 2018 - Early life exposure to green space could have beneficial effects on cognitive function
February 24, 2018 - Joint Surgery: Aspirin Equals NOAC for Post-Acute VTE Prevention
February 23, 2018 - Scientists identify new marker of arthritis in mice
February 23, 2018 - Beetroot juice supplements may benefit patients with heart failure
February 23, 2018 - New study identifies novel molecular biomarkers of preeclampsia
February 23, 2018 - Researchers discover new link between gut bacteria and obesity
Researchers shine light on ‘molecular butcher’ using neutron beams

Researchers shine light on ‘molecular butcher’ using neutron beams

image_pdfDownload PDFimage_print

Tucked away inside cell membranes, a molecular butcher does the bidding of healthy cells but also of disease agents. It has been operating out of clear view, but researchers just shined a mighty spotlight on it.

The butcher is a common enzyme called presenilin, which chops lengthy protein building blocks down to useable shorter lengths. It resides in membrane spaces that evade ready experimental detection, but in a new study, researchers at the Georgia Institute of Technology and Oak Ridge National Laboratory (ORNL) have illuminated presenilin using a neutron beam produced by the world’s most powerful research nuclear reactor.

“One third of our genome goes to work to encode intramembrane proteins,” said Raquel Lieberman, an associate professor in Georgia Tech’s School of Chemistry and Biochemistry. “Some of them are huge and do super complex biochemistry.”

The enzyme presenilin in particular is an intramembrane protease. There are four classes of these, and they are needed, among other things, for: Alerting to and defending against infectors, and cell differentiation and development.

If the latter two go wrong, that can lead to cancer.

Grainy neutron mugshot

Now, the researchers have gotten a figurative mugshot of one intramembrane protein, the presenilin. Technically speaking, the researchers worked with a presenilin cousin found in microbes — M. marisnigri intramembrane aspartyl protease or MmIAP — but here we will use presenilin and MmIAP interchangeably for simplicity’s sake.

The measurement was low-resolution but revealed enough to establish that the protein structure is more simply put together than previously believed, and that surprised the scientists.

“Our sample shows that this is a monomer all by itself,” Lieberman said. “We were expecting a dimer or a trimer.” That means it was made up of one long strand, mostly coiled up like a spring, instead of doubled-up or tripled-up curly strands.

Presenilin (MmIAP) is armed with two chemical knives, aspartates, that reliably make cuts on peptides, the subunits that make up proteins. And a second new study by the same researchers illuminated how the cleaving works.

Anybody’s peptide butcher

Presenilin can trim peptides into building blocks helpful to its own cells, or whittle bad peptide chunks that end up in amyloid-beta plaque, a suspect in Alzheimer’s disease. Or presenilin can aid and abate hepatitis C viruses by carving components it needs to reproduce.

Understanding how presenilin works could one day prove useful to medical research. “If you could find a way to interfere with it selectively, you could stop the spread of hepatitis C in the body,” Lieberman said.

The researchers, led by Lieberman and neutron scattering scientist Volker Urban from ORNL, published the revelations of the neutron scattering on February 2, 2018, in Biophysical Journal. The new insights into presenilin functioning is to officially publish in March in the Journal of Biological Chemistry, but is currently available online without embargo. First authors were Swe-Htet Naing of Georgia Tech and Ryan Oliver of Oak Ridge.

Research was funded by the National Science Foundation, the National Institutes of Health, and the U.S. Department of Energy.

Herding hydrophobic hiders

The scientists reached for the big gun when they went to the High Flux Isotope Reactor (HFIR) to make presenilin (MmIAP) come out of hiding.

HFIR’s neutron beams were cooled to minus 253 degrees Celsius (minus 424 degrees Fahrenheit) to slow the neutrons down, so they could probe molecular features of the biological samples.

Presenilin and other intramembrane proteins warrant such proverbial desperate measures. They live in a lipid environment and hate water about the way cats do, and that’s a problem for researchers studying them.

“When you have proteins that are not soluble in water, you’re in trouble,” Lieberman said. “The usual techniques to analyze them become very, very difficult, if not impossible. And when you chemically bootstrap these proteins to be able use these water-soluble methods, you have really poor chances of seeing the protein’s actual structure that performs its function.”

Form follows function

Images derived from water-based analytical methods in Lieberman’s lab have not completely jibed with presenilin’s function. For one, the enzyme’s cutting surfaces have been too far apart. The neutron beam’s revelations made more sense to the researchers.

“Our shape was tighter, and made more sense with presenilin’s function in its natural setting in the membrane,” Lieberman said.

The presenilin (MmIAP) samples examined at the HFIR were suspended in a solution friendly to the hydrophobic protein. Ironically, presenilin and other intramembrane proteases often hydrolyze peptides, in other words, they add water to them.

“These proteases are confined to the lipid cell membrane where there is no water. Since water is required for hydrolysis, it has to come from outside the membrane,” Lieberman said. “How that happens is yet another mystery that needs uncovering.”

Robust, reliable choppers

The precision and consistency, with which the presenilin homologue MmIAP cleaved peptides, impressed the researchers.

“When we used a model synthetic peptide, it cleaved only at very specific positions on the peptide,” Lieberman said. “When we switched to a real biological peptide, it also cleaved very exactly.”

The researchers put the presenilin through various mutations, which had little to no effect on its cleaving abilities. That could mean that its baseline functioning is nearly immune to genetic interference.

On a chilling note, when cutting amyloid-beta precursor peptides, the researchers observed the microbial presenilin cousin, MmIAP, always making the chop in a way notorious for amyloid’s association with Alzheimer’s disease.

“We never saw the cut that made what is typically viewed as the ‘good’ amyloid, A-beta-40,” Lieberman said. “We only saw cuts that led to the ‘bad’ amyloid, A-beta-42.”

More research would be needed to explain why that happened; if the same is true for presenilin in human cell membranes, and also if some regulator prevents the creation or accumulation of so much bad amyloid in healthy cells.

Tagged with:

About author

Related Articles